# Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India

> **NCT04827615** · NA · COMPLETED · sponsor: **Harvard School of Public Health (HSPH)** · enrollment: 11322 (actual)

## Conditions studied

- Non Communicable Diseases
- Blood Pressure
- Behavior, Health
- Blood Glucose, High
- Blood Glucose, Low
- Diabetes Type 2
- Lifestyle-related Condition
- Body Weight

## Interventions

- **BEHAVIORAL:** Ambuja Cement Foundation's Non Communicable Disease Program

## Key facts

- **NCT ID:** NCT04827615
- **Lead sponsor:** Harvard School of Public Health (HSPH)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-30
- **Primary completion:** 2024-01-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 11322 (ACTUAL)
- **Last updated:** 2025-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04827615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04827615, "Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04827615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*